Lorence H. Kim's most recent trade in Revolution Medicines Inc was a trade of 4,730 Common Stock done at an average price of $210.5 . Disclosure was reported to the exchange on Sept. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 210.50 per share. | 08 Sep 2026 | 4,730 | 4,215 (0%) | 0% | 210.5 | 995,678 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 211.36 per share. | 08 Sep 2026 | 3,844 | 371 (0%) | 0% | 211.4 | 812,463 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 208.55 per share. | 08 Sep 2026 | 3,587 | 11,798 (0%) | 0% | 208.6 | 748,081 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 209.56 per share. | 08 Sep 2026 | 2,853 | 8,945 (0%) | 0% | 209.6 | 597,875 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 207.33 per share. | 08 Sep 2026 | 999 | 15,385 (0%) | 0% | 207.3 | 207,125 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 206.60 per share. | 08 Sep 2026 | 706 | 16,384 (0%) | 0% | 206.6 | 145,863 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 212.27 per share. | 08 Sep 2026 | 371 | 0 (0%) | 0% | 212.3 | 78,752 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 203.55 per share. | 31 Aug 2026 | 26,160 | 27,114 (0%) | 0% | 203.5 | 5,324,824 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 202.48 per share. | 31 Aug 2026 | 12,919 | 53,274 (0%) | 0% | 202.5 | 2,615,864 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 204.35 per share. | 31 Aug 2026 | 7,271 | 19,843 (0%) | 0% | 204.4 | 1,485,830 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 201.47 per share. | 31 Aug 2026 | 6,597 | 66,193 (0%) | 0% | 201.5 | 1,329,117 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 205.19 per share. | 31 Aug 2026 | 2,128 | 17,715 (0%) | 0% | 205.2 | 436,640 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 206.15 per share. | 31 Aug 2026 | 625 | 17,090 (0%) | 0% | 206.2 | 128,846 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Sale of securities on an exchange or to another person at price $ 200.56 per share. | 31 Aug 2026 | 300 | 72,790 (0%) | 0% | 200.6 | 60,168 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 3,127 | 3,127 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 1,191 | 74,281 (0%) | 0% | 0 | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 359.28 per share. | 05 Mar 2026 | 557 | 4,081 (0%) | 0% | 359.3 | 200,119 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 11,574 | 11,574 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 3,142 | 73,090 (0%) | 0% | 0 | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 789 | 3,524 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 70,500 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 69,948 (0%) | 0% | 0 | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 843 | 2,735 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 65,700 (0%) | 0% | 0 | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,334 | 1,892 (0%) | 0% | - | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 558 | 558 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 22 Jul 2022 | 50,000 | 60,500 (0%) | 0% | 20 | 1,000,000 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 36,800 | 36,800 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 10,500 | 10,500 (0%) | 0% | 0 | Common Stock |